These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

646 related items for PubMed ID: 19838757

  • 1. Characterizing the HER2/neu status and metastatic potential of breast cancer stem/progenitor cells.
    Pommier SJ, Quan GG, Christante D, Muller P, Newell AE, Olson SB, Diggs B, Muldoon L, Neuwelt E, Pommier RF.
    Ann Surg Oncol; 2010 Feb; 17(2):613-23. PubMed ID: 19838757
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A novel mouse model of human breast cancer stem-like cells with high CD44+CD24-/lower phenotype metastasis to human bone.
    Ling LJ, Wang S, Liu XA, Shen EC, Ding Q, Lu C, Xu J, Cao QH, Zhu HQ, Wang F.
    Chin Med J (Engl); 2008 Oct 20; 121(20):1980-6. PubMed ID: 19080260
    [Abstract] [Full Text] [Related]

  • 4. Detection of Her2/neu, c-MYC and ZNF217 gene amplification during breast cancer progression using fluorescence in situ hybridization.
    Shimada M, Imura J, Kozaki T, Fujimori T, Asakawa S, Shimizu N, Kawaguchi R.
    Oncol Rep; 2005 Apr 20; 13(4):633-41. PubMed ID: 15756435
    [Abstract] [Full Text] [Related]

  • 5. HER2 status in breast cancer determined by IHC and FISH: comparison of the results.
    Mrozkowiak A, Olszewski WP, Piaścik A, Olszewski WT.
    Pol J Pathol; 2004 Apr 20; 55(4):165-71. PubMed ID: 15757204
    [Abstract] [Full Text] [Related]

  • 6. Real-time RT-PCR analysis for evaluating the Her2/neu status in breast cancer.
    Cuadros M, Talavera P, López FJ, García-Peréz I, Blanco A, Concha A.
    Pathobiology; 2010 Apr 20; 77(1):38-45. PubMed ID: 20185966
    [Abstract] [Full Text] [Related]

  • 7. The role of HER2/neu overexpression/amplification in the progression of ductal carcinoma in situ to invasive carcinoma of the breast.
    Latta EK, Tjan S, Parkes RK, O'Malley FP.
    Mod Pathol; 2002 Dec 20; 15(12):1318-25. PubMed ID: 12481013
    [Abstract] [Full Text] [Related]

  • 8. Topoisomerase IIalpha gene status and prediction of pathological complete remission after anthracycline-based neoadjuvant chemotherapy in endocrine non-responsive Her2/neu-positive breast cancer.
    Orlando L, Del Curto B, Gandini S, Ghisini R, Pietri E, Torrisi R, Balduzzi A, Cardillo A, Dellapasqua S, Veronesi P, Viale G, Goldhirsch A, Colleoni M.
    Breast; 2008 Oct 20; 17(5):506-11. PubMed ID: 18456496
    [Abstract] [Full Text] [Related]

  • 9. Expression of HER2 and the coamplified genes GRB7 and MLN64 in human breast cancer: quantitative real-time reverse transcription-PCR as a diagnostic alternative to immunohistochemistry and fluorescence in situ hybridization.
    Vinatzer U, Dampier B, Streubel B, Pacher M, Seewald MJ, Stratowa C, Kaserer K, Schreiber M.
    Clin Cancer Res; 2005 Dec 01; 11(23):8348-57. PubMed ID: 16322295
    [Abstract] [Full Text] [Related]

  • 10. Clinicopathological relevance of HER2/neu and a related gene-protein cubic regression correlation in colorectal adenocarcinomas in Taiwan.
    Li JW, Chuang TC, Yang AH, Hsu CK, Kao MC.
    Int J Oncol; 2005 Apr 01; 26(4):933-43. PubMed ID: 15753987
    [Abstract] [Full Text] [Related]

  • 11. [Expression of Her2/neu in locally advanced bladder cancer: implication for a molecular targeted therapy].
    Wülfing C, von Struensee D, Bierer S, Bögemann M, Hertle L, Eltze E.
    Aktuelle Urol; 2005 Sep 01; 36(5):423-9. PubMed ID: 16163605
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of HER-2/neu oncogene status in breast tumors on tissue microarrays.
    Zhang D, Salto-Tellez M, Do E, Putti TC, Koay ES.
    Hum Pathol; 2003 Apr 01; 34(4):362-8. PubMed ID: 12733117
    [Abstract] [Full Text] [Related]

  • 13. Histopathologic characteristics predicting HER-2/neu amplification in breast cancer.
    Prati R, Apple SK, He J, Gornbein JA, Chang HR.
    Breast J; 2005 Apr 01; 11(6):433-9. PubMed ID: 16297088
    [Abstract] [Full Text] [Related]

  • 14. Downregulation of HER2/neu receptor by solamargine enhances anticancer drug-mediated cytotoxicity in breast cancer cells with high-expressing HER2/neu.
    Shiu LY, Liang CH, Huang YS, Sheu HM, Kuo KW.
    Cell Biol Toxicol; 2008 Jan 01; 24(1):1-10. PubMed ID: 17885815
    [Abstract] [Full Text] [Related]

  • 15. Prognostic utility of fluorescence in situ hybridization for determining HER2 gene amplification in breast cancer.
    Kammori M, Kurabayashi R, Kashio M, Sakamoto A, Yoshimoto M, Amano S, Kaminishi M, Yamada T, Takubo K.
    Oncol Rep; 2008 Mar 01; 19(3):651-6. PubMed ID: 18288397
    [Abstract] [Full Text] [Related]

  • 16. Estrogen receptor-negative and human epidermal growth factor receptor 2-negative breast cancer tissue have the highest Ki-67 labeling index and EGFR expression: gene amplification does not contribute to EGFR expression.
    Umemura S, Takekoshi S, Suzuki Y, Saitoh Y, Tokuda Y, Osamura RY.
    Oncol Rep; 2005 Aug 01; 14(2):337-43. PubMed ID: 16012712
    [Abstract] [Full Text] [Related]

  • 17. Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and Her2/neu-overexpressing phenotypes.
    Kim MJ, Ro JY, Ahn SH, Kim HH, Kim SB, Gong G.
    Hum Pathol; 2006 Sep 01; 37(9):1217-26. PubMed ID: 16938528
    [Abstract] [Full Text] [Related]

  • 18. Expression of Her2/neu, steroid receptors (ER and PR), Ki67 and p53 in invasive mammary ductal carcinoma associated with ductal carcinoma In Situ (DCIS) Versus invasive breast cancer alone.
    Mylonas I, Makovitzky J, Jeschke U, Briese V, Friese K, Gerber B.
    Anticancer Res; 2005 Sep 01; 25(3A):1719-23. PubMed ID: 16033090
    [Abstract] [Full Text] [Related]

  • 19. Numb protein expression correlates with a basal-like phenotype and cancer stem cell markers in primary breast cancer.
    Rennstam K, McMichael N, Berglund P, Honeth G, Hegardt C, Rydén L, Luts L, Bendahl PO, Hedenfalk I.
    Breast Cancer Res Treat; 2010 Jul 01; 122(2):315-24. PubMed ID: 19795205
    [Abstract] [Full Text] [Related]

  • 20. Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ.
    Half E, Tang XM, Gwyn K, Sahin A, Wathen K, Sinicrope FA.
    Cancer Res; 2002 Mar 15; 62(6):1676-81. PubMed ID: 11912139
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.